Clinical trial

Role of Curcumin in Paclitaxel Induced PN

NCT05966441

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-08-30

PhasePHASE2

Study timeline

Study start (estimated)2023-08-30Date precision: day

Registry last updated2023-07-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chemotherapy-induced Peripheral Neuropathyunresolved

Interventions

CurcuminDIETARY_SUPPLEMENT

PaclitaxelDRUG · verified · RxNorm: paclitaxel

Sponsors & collaborators

Ain Shams Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05966441 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.